Účinnost xx 31.3.2006 xx 22.9.2007 (xx xxxxxx x. 230/2007 Xx.)
Xxxxxxx x. 6 x vyhlášce č. 26/2001 Xx.
Xxxx 1
Seznam xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx prostředcích, xxxxxxxx xxxxxxxxx xxxxxxxxxxx, xxxxxxxxx xx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx x podmínky použití
Za xxxxxxxxxxx přísady xx xxxxxxxx x xxxx xxxxx, uvedených x xxxxxxx x. 6. x xx soli xxxxxxxx, sodné, xxxxxxxx, xxxxxxxxx, xxxxxx, xxxxxxxxxxxxxx x xxxx chloridy, xxxxxxx, xxxxxx, xxxxxx x methyl-, xxxxx-, xxxxxx, xxxxxxxxx-, xxxxx-, xxxxxxxx- x xxxxxxxxxxx.
Xxxxx xxxxxxxx symbolem (+) xxx xxxxxxxx xx xxxxxxxxxxxx prostředku xxxxxx x xxxxxxxxxxx jiné, xxx xx x xxxxxxx x. 6 xxxxxxx, xxx jen xxx xxxxxxxxxx xxxxx, xxxxx jsou xxxxxx x xxxxxxxxxxx funkce, xxxxxxxx xxxxx xxxxxxx xxxxxxxxxxxx prostředku, například xxxx xxxxxxxxxxx xx xxxxx xxxx xxxxxxx xxxxx xxxxx do xxxxxxx.
Xxxxxxx xxxxx xxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx mít xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxx x xxxxx xxx xxxxxxxxx xxxxxxxxxx xxxxxxx. Xxx xxxxxxxxx x xxxx xxxxxxxxxx xxxxx x xxxxxxx xxxxxxxx. Xxxx xxxxx xxxxxx xxxxxxxx xx přílohy x. 6.
Všechny xxxxxxx xxxxxxxxxx xxxxxxxxxx, které xxxxxxxx xxxxxxxxxxx nebo xxxxx formaldehyd xxxxxxxxxx, xxxx xxx na xxxxx xxxxxxxx varováním "xxxxxxxx xxxxxxxxxxx", xxxxx xxxxxxxxxxx xxxxxxxxxxxx xx xxxxxxxx výrobku xxxxxxxx 0,05 xxxxxxx.
___________________________________________________________________________________________
Xxx. Xxxxx Xxxxxxxxx Xxxxxxx x xxxxxxxxx Xxxxxxxx použití
číslo povolená xxxxxxxxxxx x xxxxxxxx, xxxxx xxxx
xxx xxxxxxxxx xx obalu
___________________________________________________________________________________________
a b x x x
___________________________________________________________________________________________
1 Xxxxxxxx xxxxxxxx•; 0,5 % v xxxxxxxx xx xxxxxxxx
/Xxxxxxx xxxx/°, xxxx soli
a estery (+)
___________________________________________________________________________________________
2 Xxxxxxxx xxxxxxxxxx•; 2 % x xxxxxxxx xx kyselinu
/Propionic xxxx/°x xxxx soli
___________________________________________________________________________________________
3 Xxxxxxxx salicilová•; 0,5 % x xxxxxxxx xx xxxxxxxx Xxxxx xxx použito xx xxxxxxx xxx Xxxxxxxxxx xxx xxxx
/Xxxxxxxxx acid /°x xxxx děti xx 3 xxx s xxxxxxxx xxxxxxx. xx 3 xxx (1).
xxxx (+)
___________________________________________________________________________________________
4 Kyselina xxxxxxx (xxxx- 0,6 % x xxxxxxxx xx xxxxxxxx
-2,4-xxxxxxx xxxxxxxx)•;
/Xxxxxx xxxx (xxxx-2,4-
-xxxxxxx xxxx)/°x její
soli (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx xxxxxxxxxx pro Xxxxxxxx x xxxxxxxxxxxxxx
/Xxxxxxxxxxxx/°x xxxxxxx xxx) xxxxxxxx (xxxxxxxx).
xxxxxxxxxxxxxxx• ; 0,1 % (xxxxxxxxxx pro hygienu
/Paraformaldehyde/°(+) úst) x xxxxxxxx xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx xxxxxxxxxx
___________________________________________________________________________________________
7 Bifenyl.-2-ol(o-fenyl- 0,2 % x xxxxxxxx xx xxxxx
xxxxx)•; /Xxxxxxxx-2-
-xx(x-xxxxxxxxxxxx/°)
x jeho xxxx (+)
___________________________________________________________________________________________
8 Xxxxxxxxx xxxxxxxxx• 0,5 % Povolen xxx xxx xxxxxxxxxx,
/Xxxxxxxxxx xxxx/* (+) xxxxx xx xxxxxxxxx. Zakázán
v xxxxxxxxxxxx xxxxx hygieny.
___________________________________________________________________________________________
9 Xxxxxxxxxxx xxxxxxxxxx 0,2 % x xxxxxxxx xx xxxxx XX2
x hydrogensiřičitany
/Inorganic sulphites xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx xxxxx 0,1 % Xxx xxx xxxxxxxxxx, xxxxx
/Xxxxxx xxxxxx/° xx xxxxxxxxx.
___________________________________________________________________________________________
11 Xxxxxxxxxxxx• 0,5 % Xxxxxxxx v xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (xxxxxxxx). xxxxxxxxxxxx.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % jako xxxxxxxx xxx xxxxx
-xxxxxxxxxxxxxxx•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % xxxx xxxxxxxx xxx směs
acid/°a xxxx soli x xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Xxxxxx-6-xxxxxx-2,3- 0,6 % x xxxxxxxx xx xxxxxxxx Xxxxxxxx v xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (sprejích).
-dion•; /Xxxxxx-6-xxxxxx-
-xxxxx-2,4(3X)-xxxxx
(Xxxxxxxxxxxxx xxxx)/°
x jeho soli
___________________________________________________________________________________________
14 Xxxxxxxx xxxxxxxx•; 0,5 v xxxxxxxx xx xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx xxx/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x xxxx xxxx xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Thiomersal/* 0,007 % (xxxx Xx) ve xxxxx x Xxxxx xxx xxxxxxxxxx x xxxxxx Xxxxxxxx xxxxxxxxxx.
xxxxxxxxx sloučeninami xxxxx x xxxxxxxxxx xxx.
xxxxxxxxxx touto vyhláškou
zůstává xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % Xx
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx xxxx• 0,007 % (xxxx Xx) xx xxxxx s Xxxxx xxx xxxxxxxxxx x líčení Obsahuje
(včetně xxxxxx) xxxxxxxxx xxxxxxxxxxxx rtuti a xxxxxxxxxx okolí xxx. xxxxxxxxxxxxx
/Xxxxxxxxxxxxxx xxxxx xxxxxxxxxx touto vyhláškou xxxxxxxxxx.
(xxxxxxxxx borate)/° zůstává xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Xx
___________________________________________________________________________________________
18 Xxxxxxxx xxxx-10-xxxxx•; 0,2 % x xxxxxxxx na kyselinu
/Undec-10-enoic xxxx/°
x xxxx xxxx(+)
___________________________________________________________________________________________
19 Xxxxxxxxx 0,1 %
/Hexetidine/* (+)
___________________________________________________________________________________________
20 5-brom-5-nitro-1,3-dioxan 0,1 % Xxx xx prostředků, xxxxx xx
(Xxxxxxxx)• /5-Xxxxx-5- xxxxxxxxx.
-xxxxx-1,3-xxxxxxx/° Xxxxxxx xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
21 Xxxxxxxx /Bronopol/* (+) 0,1 % Xxxxxxx tvorbě xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
alkohol• /2,4-Xxxxxxxx-
xxxxxx xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Xxxxxxxx xxxxxxx: 3,3´,4,4´-
/Xxxxxxxxxxxx/* (+) xxxxxxxxxxxxxxxxxxx xxxx xxx 1
xxx 3,3´,4,4´-tetrachlorazoxy-
benzen xxxx xxx 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Xxxxxxx x xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx xx kontaktu
se xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Triclosan/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-chlor-3,5-dimethylfenol)•
/4-Chloro-3,5-xylenol/°(+)
___________________________________________________________________________________________
27 3,3´-Xxx[1-(xxxxxxx- 0,6 %
xxxxxx)-2,5-xxxxxxxxxx-
xxxxxxx-4-xx]-1,1´-
xxxxxxxxxxxxxxxxxx
(xxxxxxxxxxxxxxxxxxxxxx)•
/3,3´--Xxx(1-xxxxxxx-
xxxxxx-2,5-xxxxxxxxxx-
xxxxxxx-4-xx)-1,1´-xxxxxx-
xxx-xxxxx ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Xxxx-1-xxxxxxxxxxxx 0,3 %
biguanid-hydrochlorid•
/Poly-(1-hexamethyl-
enbiguanide xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Fenoxyethan-1-ol• 1 %
/2-Xxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
30 Xxxxxxxxxxxxxxxxxxxx 0,15 %
(xxxxxxxxxx, urotropin)•
/Hexamethylentetramine
(methenamine*)/°(+)
___________________________________________________________________________________________
31 Xxxxxxxxxx-3-xxxxxx- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Xxxxxxxxxxx)-1- 0,5 %
(xxxxxxxx-1-xx)-3,3´-
xxxxxxxxxxxxx-2-xx•
/1-(4-Xxxxxxxxxxxxx)-
-1-(xxxxxxxx-1-xx)3,3-
-xxxxxxxxxxxxx-2xxx/°
(+)
___________________________________________________________________________________________
33 1,3-Xxx(xxxxxxxxxxxxx)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Bis
(hydroxy-methyl)-5,5-
-dimethyl-imidazolidine-
-2,4-dione/°(+)
___________________________________________________________________________________________
34 Xxxxxxxxxxxxx• 1 %
/Xxxxxx alcohol/°
___________________________________________________________________________________________
35 1-Xxxxxxx-4-xxxxxx-6- 1 % Pro xxxxxxxxxx, xxxxx xx xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Pro ostatní xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx x xxxxxxxxxx-
xxxxxxx• (xxxxxxxxx) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx xxx xxxxxxxxxx, xxxxx
xxxxxxxxxxx• xx xxxxxxxxx.
/1,2-Xxxxxxx-2,4-
-xxxxxxxxxxxxx°
XXXXXXXXXXXXX
XXXXXXXXXXXXXX•
___________________________________________________________________________________________
37 6,6´-Dibrom-4,4-´dichlor- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-xxxxxxxxx-3-xxxxxxxxxxx)•
/4-Xxxxxxxxx-x-xxxxxx/°
___________________________________________________________________________________________
39 Xxxx 5-xxxxx-2-xxxxxx- 0,0015 % (Směs v xxxxxx 3 :1
-xxxxxxxxxx-3(2X)-xxx• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx a 2-xxxxxxxxxxxxxxxx-3(2X)-xx
xxxxxxxxx-3(2X)-xxx/°x
2-xxxxxxxxxxxxxxxx-3(2X)-
-xxx• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x chloridem
hořečnatým /xxxxxxxxx
xxxxxxxx/°x xxxxxxxxxx
xxxxxxxxxx /magnesium
nitrate/°
___________________________________________________________________________________________
40 2-Xxxxxx-4-xxxxxxxxxx• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Obsahuje
/2-Chloracetamide/° chloracetamid.
___________________________________________________________________________________________
42 Xxxxxxxxxxxx• 0,3 % v xxxxxxxx xx chlorhexidin
/Chlorhexidine/* x xxxx
xxxxxxxxxx, /xxxxxxxxxxx/°,
xxxxxxxx /xxxxxxxxx/ a
dihydrochlorid
/dihydrochloride/°(+)
___________________________________________________________________________________________
43 1-Xxxxxxxxxxxx-2-xx• 1,0 % Xxx xxx xxxxxxxxxx, xxxxx se
/1-Phenoxypropan-2-ol/° oplachují.
___________________________________________________________________________________________
44 Xxxxx (X12 - C22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -chlorid•
/Alkyl (X12 - X22) xxxxxxxxx
xxxxxxxx-xxxxxxx
x xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % xX konečného xxxxxxxx xxxxx
-xxxxxxxxxx• /4,4-Xx- xxx xxxxx než 6.
xxxxxx-1,3-xxxxxxxxxxx/
___________________________________________________________________________________________
46 1-[1,3-Bis(hydroxy- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Hexan-1,6-diyldi- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x jeho xxxx xxxxxx
xxxxxxxxxxx (2-xxxxxxx-
-xxxxx-1-xxxxxxxxx)•
/xxxxxxxxxxx/°x 4-hydro-
xybenzoátu• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Xxxxxxxx x rozprašovačích Obsahuje
(pentandial)• aerosolů (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (xxx xxxxxx
(Xxxxxxx-1,5-xxxx)/° glutaraldehydu x
xxxxxxxx produktu
vyšším než 0,05 %)
___________________________________________________________________________________________
49 5-Xxxxx-3,7-xxxxx-1- 0,3 % Xxxxxxx x prostředcích xxxxx
-xxxxxxxxxx[3.3.0]xxxxx• xxxxxxx x v xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx do xxxxxxxx
-xxxxxxxxxx[3.3.0] xx xxxxxxxx.
xxxxxx/°
___________________________________________________________________________________________
50 3-(4-Chlorfenoxy)-propan- 0,3 %
-1,2diol• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx sodný, X-(xxxxxxx-
xxxxxx)-xxxxxxxx xxxxx,•
/Xxxxxx hydroxymethyla-
minoacetate, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx xxxxxxxx zakot- 0,004 % x xxxxxxxx xx XxXx 20 % (hmotn.)AgCl xx XxX2
xxxx xx oxidu xxxxxxxxxxx Zakázán v xxxxxxxxxxxx xxx xxxx xx
/Xxxxxx xxxxxxxx deposited 3 let, x xxxxxxxxxxxx xxxxx hygieny
on Xxxxxxxx xxxxxxx/° x v xxxxxxxxxxxx xxxxxxxxxxxx xx
xxxxx xxx a xx xxx.
___________________________________________________________________________________________
53 Xxxxxx{2-[2-(xxxxxxxxxxxx- 0,1 % x) prostředky, které xx xxxxxxxxx;
xxxx)xxxxxx]xxxxx}xx- x) prostřeky, xxxxx xxxxxxxxx xx xxxx, vyjma xxxxxxxxxx
xxxxxxxxxxxxx-xxxxxxx xxx xxxx x xxxxxx ústní
Benzethonium-chlorid•
BENZETHONIUM XXXXXXXX°
___________________________________________________________________________________________
54 Xxxxx(X8 - X18) (xxxxxx) 0,1 % x xxxxxxxx xx Zamezte styku x očima.
dimethylamonium-chlorid, benzalkonium-chlorid
-bromid a xxx x cukernou
kyselinou (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx x xxx x
xxxxxxxx xxxxxxxxx)•
/Xxxxxxxxxxxx xxxxxxxx,
xxxxxxx xxx
xxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
55 Benzylhemiformal 0,15 % Xxx pro xxxxxxx, xxxxx se
(benzyloxymethanol)• xxxxxxxxxx xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Xxxxx xx xxxxxxxx v Obsahuje xxx.
-xxxxxxxxxxxxx• xxxxxxxxxxxx ústní hygieny x x
/3-Xxxx-2-xxxxxxxx-xxxxx- xxxxxxxxxxxx x xxxx o xxx.
xxxxxxxxx/° 2. Xxxxx xxxxxxxxxxx x
xxxxxxxxxxxx, xxxxx xxxx určeny
k xxxx, xxx xxxxxxxxx xx
xxxxxxx, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Obsahuje jod.
___________________________________________________________________________________________
57 2-methylisothiazol- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Xxxxx xxxxx xxx xxxxxxx, xxxxx xx xxxxx xxx xxxxxxx xxx xxxx xx 3 let x xxxxx xxxxxxxxx x xxxxxxxxxxxx kontaktu x xxxx.
(*) X xxxx xxxxxxx xx xxxxx způsobem xxxxxxx xxxxx xxxxxxxxxxx x xxxxxxx mezinárodně nechráněných xxxxx xxx farmaceutické xxxxxxx "Xxxxxxxx xxxxx-xxx 1975, Xxxxxxxxxxxxx Non-proprietary Xxxxx (INN) for xxxxxxxxxxxxxx xxxxxxxx Xxxxx 1,33 xx xxxxxxxx XXX", XXX, Xxxxxx, Xxxxxx 1975.
(•) X xxxx xxxxxxx xx xxxxx způsobem označen xxxxx vytvořený xxxxx "Xxxxxxxx xxxxxxxxxxx organických xxxxxxxxx xxxxx XXXXX (Xxxxxxxxxx 1993)", Xxxxxxxx, Xxxxx 2000.
(°) V xxxx xxxxxxx xx xxxxx xxxxxxxx xxxxxxx xxxxx x xxxxxxxxx xxxxxx, xxxxxxxx x xxxxxxxxx "Xxx Cosmetics Xxxxxxxxx 76/768/XXX", Colipa, Xxxxxxxx, March 2000.
Xxxx 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxxx, nejvyšší xxxxxxxxx koncentrace, xxxxxxxxx xx čistotu xxxxxxxxx xxxxxxxxxxxxx přísad x xxxxxxxx xxxxxxx
_______________________________________________________________________________________
Xxx. číslo Látka Maximální Xxxxxxx x Xxxxxxxx xxxxxxx x xxxxxxxx,
xxxxxxxx požadavky která xxxx xxx xxxxxxxxx xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x x c x x
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Xxxxxxxx: V xxxxxxxx xxxx tato xxxxxxx xxxxxxxxxx xxxxxx xxxxx.